Navigation Links
STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
Date:8/22/2012

MONROVIA, Calif., Aug. 22, 2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it has signed a lease on a 26,000 square foot building immediately adjacent to its current facility in Monrovia, California.  The new building will allow the Company to accommodate the needs associated with its previously announced manufacturing consolidation to Monrovia, as well as provide space for additional growth. The lease is for an eight year period beginning approximately at the end of November 2012, assuming all contingencies are met.  There will be some cash charges during the fourth quarter for tenant improvements prior to taking possession, which will not affect the P&L.

"We are pleased that we are able to expand our operations within the same building complex here in Monrovia.  Since our decision to consolidate manufacturing in California, we have been looking for additional space to accommodate our finished goods inventory and shipping departments within the same area as our current facility," said Barry G. Caldwell, president and CEO of STAAR. "This new building is ideal and offers significant advantages, allowing us more options for future growth while keeping all the Monrovia functions in basically the same facility for at least the next eight years."

STAAR's current facility in Monrovia is 44,000 square feet.  The new building is directly adjacent to the current building, which will allow connection of the two buildings via two direct hallways. In addition, the new building comes with an additional 57 parking spots.

"With the new building, we have gained flexibility in our working processes that will help drive enhanced efficiencies and productivity," Mr. Caldwell continued.  "For example, the sales, marketing, R&D and regulatory functions will be positioned in the same work area to enhance communications and working relations. In the past our current facility created challenges to positive cross-functional teamwork.  We will gain additional space to hold training sessions, all employee meetings, and other similar sessions in one space, which we are not able to do today.  Finally, parking is at a premium in Monrovia and the new spaces will satisfy current needs and future needs as we add additional work shifts.  While more space than we currently need, we expect the new building will be quickly utilized to accommodate our growth over the next several years."The manufacturing consolidation project at STAAR has been underway for over two years and is expected to be complete by the end of next year.  The manufacturing of the Visian® ICL® in Switzerland and preloaded IOLs in Japan will move to Monrovia as will the Collamer raw material process from Aliso Viejo, California.  The consolidation is expected to add to the expanding gross margin percentage as well as reduce the Company's tax rate from 50% in 2011 to 10% in 2014.  The cost savings over a seven year period is expected to exceed $100 million. 

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye.  All of these lenses are foldable, which permits the surgeon to insert them through a small incision.  STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL."  A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL."  Over 300,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com.  STAAR has approximately 300 full time employees and markets lenses in approximately 50 countries.  Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA.  For more information, please visit the Company's website at www.staar.com or call 626-303-7902. 

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material. 

Safe HarborAll statements in this press release that are not statements of historical fact are forward-looking statements, including statements about STAAR's expectations for growth of its business, the completion of its manufacturing consolidation plan and any financial benefits to be derived from consolidation. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties include unexpected costs or delays that could reduce or eliminate the expected benefits of our consolidation plans, delays in anticipated regulatory approvals in various global markets and unexpected changes in U.S. tax laws which could delay use of net operating losses. CONTACT:

Investors

Media EVC Group

EVC GroupDouglas Sherk, 415-652-9100

Chris GaleJenifer Kirtland, 415-568-9349

646-201-5431 


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical To Present At The 32nd Annual Canaccord Growth Conference
2. STAAR Surgical Reports Second Quarter 2012 Financial Results
3. STAAR Surgical Provides Outlook On Second Quarter 2012 Financial Results
4. STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
5. B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference
6. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
7. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
8. Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments and Electrosurgical Devices) - Global forecast, Market Share, size, growth and industry analysis (2010-2017)
9. Regional Medical Center at Memphis Completes Rapid Six-Month Implementation of Comprehensive Perioperative and Anesthesia Solution from Surgical Information Systems
10. Global Information Inc Offers Big Discounts on Market Forecasts for Surgical Sealants, Wound Closure Products, Spine Surgery Technology, and More
11. RoundTable Healthcare Partners Announces Sale of Aspen Surgical Products Holding, Inc. to Hill-Rom Holdings, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):